Antibiotic effects on gut-derived short chain fatty acid pools in healthy volunteers
Short-chain fatty acids (SCFAs) are vital microbial metabolites that maintain gut health and immune function. Despite the established deleterious effect of antibiotics on anaerobic bacteria in the gut, the longitudinal effects of antibiotics on SCFA pool dynamics remain poorly characterized in humans. This study aimed to characterize depletion and recovery of linear and branched SCFAs and to explore microbial taxa associated with changes to SCFA pools after antibiotic exposure. This was a secondary analysis of a phase 1, randomized, nonblinded clinical trial in young healthy volunteers given a 10-day course of oral vancomycin, omadacycline, or moxifloxacin. Fecal samples were collected at baseline, during antibiotics, and follow-up visits for SCFA determinations and amplicon-based microbiome characterizations. Mixed effects models demonstrated that vancomycin produced global suppression of SCFAs pool relative to baseline, indicating broad suppression of microbial fermentation. Although all antibiotics reduced SCFA levels during treatment, vancomycin associated changes were most evident for branched SCFAs vs. comparators. Vancomycin shifted the fermentation balance by disproportionately suppressing linear SCFAs, reflected by a lower linear-to-branched SCFA ratio. In parallel, Clostridiales abundance declined most markedly after vancomycin, with more moderate reductions after omadacycline and moxifloxacin. Moxifloxacin and omadacycline but not vancomycin showed early recovery of butyrate-production capacity by qPCR. In this longitudinal analysis of healthy volunteers, vancomycin caused global suppression of microbial fermentation, with marked depletion of linear and branched SCFAs consistent with disproportionate suppression of fiber fermentation relative to amino acid fermentation.
Authors
- Blake Hanson (ORCID: https://orcid.org/0000-0003-2949-7818)
- Sigmund J. Haidacher (ORCID: https://orcid.org/0000-0002-6103-1906)
- Abdulwhab Shremo Msdi (ORCID: https://orcid.org/0009-0009-1582-0611)
- Taryn A Eubank (ORCID: https://orcid.org/0000-0002-6645-406X)
- Chenlin Hu (ORCID: https://orcid.org/0000-0002-0444-2127)
- Thomas D. Horvath (ORCID: https://orcid.org/0000-0001-9761-3484)
- Kevin W. Garey (ORCID: https://orcid.org/0000-0003-2063-7503)
- Jinhee Jo (ORCID: https://orcid.org/0000-0002-4772-188X)
- Hossaena Ayele
- M. Jahangir Alam (ORCID: https://orcid.org/0000-0002-2145-4103)
- Khurshida Begum (ORCID: https://orcid.org/0000-0003-2039-1531)
- Xi Lu (ORCID: https://orcid.org/0009-0008-9670-5369)
Institutions
- Baylor College of Medicine (US)
- Texas Children's Hospital (US)
- University of Houston (US)
- The University of Texas Health Science Center at Houston (US)
Publication Details
- Journal
- Gut Microbes
- Published
- 2026-11-21
- DOI
- https://doi.org/10.1080/19490976.2026.2765066
- Primary Topic
- Gut microbiota and health
- Type
- article
- Field-Weighted Citation Impact
- 0.00